Showing results (11-20 of 84) with videos related to
Sort By:
Pageof 9
Contemporary Clinical Trials|July 16, 2023
Platform trials to evaluate the benefit-risk of COVID-19 therapeutics: Successes, learnings, and recommendations for future pandemicsJoan Buenconsejo, Ran Liao, Junjing Lin, et al.Therapeutic Innovation & Regulatory Science|June 10, 2020
Real-World Evidence Utilization in Clinical Development Reflected by US Product Labeling: Statistical ReviewYodit Seifu, Margaret Gamalo-Siebers, Friederike M-S Barthel, et al.Methods and Protocols|May 27, 2026
Large Language Models for Clinical Narrative Processing: Methods, Applications, and ChallengesAchilleas Livieratos, Junjing Lin, Paraskevi Chasani, et al.Journal of Biopharmaceutical Statistics|February 13, 2019
Semi-parametric Bayesian regression for subgroup analysis in clinical trialsMargaret Gamalo-Siebers, Ram TiwariPlos One|February 13, 2026
MetaMind: A multi-agent transformer-driven framework for automated network meta-analysesAchilleas Livieratos, Maria Kudela, Yuxi Zhao, et al.Pharmaceutical Statistics|June 29, 2022
Win ratio approach for analyzing composite time-to-event endpoint with opposite treatment effects in its componentsRan Liao, Sujatro Chakladar, Margaret GamaloJournal of Biopharmaceutical Statistics|August 18, 2021
Estimands, Handling of Missing Data and Impact on Assumed Effect Size and Power in Pivotal COVID-19 Treatment TrialsSujatro Chakladar, Ran Liao, Margaret GamaloJournal of Biopharmaceutical Statistics|December 25, 2025
Common risk difference and corresponding confidence interval adjusted for multiple factors - comparison of seven different methodsYuxi Zhao, Vivek Pradhan, Margaret GamaloJournal of Biopharmaceutical Statistics|August 23, 2016
Flexible shrinkage estimation of subgroup effects through Dirichlet process priorsMargaret Gamalo-Siebers, Ram Tiwari, Lisa LaVangeJournal of the American Academy of Dermatology|June 6, 2021
Efficacy and safety of the oral Janus kinase inhibitor baricitinib in the treatment of adults with alopecia areata: Phase 2 results from a randomized controlled studyBrett King, Justin Ko, Seth Forman, et al.Pageof 9